MSLT, MWT & Other Studies

Why Microsleeps May Redefine ‘Quality of Wake’ in Narcolepsy Type 1

Phase 3 data on the orexin agonist oveporexton suggests that reducing microsleep frequency offers a more accurate reflection of real-world treatment response than traditional wakefulness tests alone.

How Should MSLT Protocols Differ in Children?
Real-Time Sleep Scoring Software Is Here. Can It Help Sleep Techs Score Studies for Hypersomnia?
Assessing Daytime Sleepiness: AASM Updates Protocols for MSLT & MWT
We May Need to Rethink the Timing of Narcolepsy Diagnostics
Conduct MSLT While Patient Is on Antidepressants? ‘Look at Other Options’
New EEG Insights Offer Window into Hypersomnia Differential Diagnosis

MSLT, MWT & Other Studies

Researchers Get Closer to Real Life Biomarker to Differentiate Hypersomnias

Narcolepsy type 1 is distinct from other hypersomnias in several ways. People diagnosed with it must have sleepiness and either objectively low levels orexin or cataplexy and a positive multiple sleep latency test.